Johnson & Johnson (J&J) has reported new data from the Phase III ICONIC-TOTAL trial, assessing icotrokinra in treating plaque ...

Once-daily ZORYVE foam provides powerful clearance and rapid itch relief from head to toe with no limitation on duration of use More than half of the nearly 9 million people in the United States with ...

“Treating plaque psoriasis in areas like the scalp ... including hard-to-treat areas from head to toe. This is the fifth approval for ZORYVE in less than three years and furthers our mission ...

Icotrokinra led to high rates of skin clearance in patients with scalp and genital psoriasis, according to results from the ICONIC-TOTAL study.

Johnson & Johnson (J&J) and Protagonist Therapeutics’ investigational oral peptide icotrokinra (JNJ-2113) has been associated with significant skin clearance in patients with difficult-to-treat ...

Findings also showed that among the small subset of patients with hand and/or foot psoriasis ... treatment paradigm in moderate-to-severe plaque psoriasis, by offering a combination of skin ...

I broke out in guttate, inverse, and plaque psoriasis from head to toe. It lasted for seven months. For those seven months, I didn’t feel like myself. The pain was constant. I couldn’t be ...

and/or hands and feet) with overall IGA score of 0 or 1 with at least a 2-grade improvement as the primary endpoint. Plaque psoriasis (PsO) is a chronic immune-mediated disease resulting in ...

In the smaller subset of patients with hand/foot psoriasis, patients showed a numerically higher rate of skin clearance at Week 16 with 42% achieving a hand and/or foot Physician's Global ...

and/or hands and feet) with overall IGA score of 0 or 1 with at least a 2-grade improvement as the primary endpoint. Plaque psoriasis (PsO) is a chronic immune-mediated disease resulting in ...